Chemistry and Biodiversity (2020)
Update date:2022-08-02
Topics:
Patel, Harun M.
Palkar, Mahesh
Karpoormath, Rajshekhar
Drug resistance tuberculosis is one of the challenging tasks that dictates the desperate need for the development of new antitubercular agents which operate via novel modes of action. Here, we are reporting on 4-aminoquinazolines as M. tuberculosis N-acetylglucosamine-1-phosphate uridyltransferase (GlmUMTB) inhibitors to overcome the problem of the MDR-TB. Amongst the synthesized compounds, two of them were observed to be the effective compounds of the series (IC50=6.4 μM (H37Rv), MIC=25 μM (MDR-TB) and IC50=2.9 μM (H37Rv), MIC=6.25 μM (MDR-TB), respectively).
View MoreContact:+91 - 22 - 26355700
Address:17, Lotus Business Park, Andheri West
Xi'an Unique Electronic and Chemical Co., Ltd.
Contact:+86-029-88238008
Address:1703# B BUILDING WEST ELECTRONIC ZONE, XI'AN, CHINA
Shanghai Standard Biotech Co., Ltd.
Contact:+86-18502101150
Address:Room 103, Building 2nd, NO.720, Cailun Road , Pudong District, Shanghai, China
Contact:0086-21-80264647
Address:RM 202, NO 1602 West Zhongshan Rd, Shanghai, China
Contact:--
Address:80G, No.1 Building, Guodu Development Mansion, No. 182 Zhaohui Road, Hangzhou City, Zhejiang Province,China.
Doi:10.1016/j.tetlet.2016.11.081
(2017)Doi:10.1016/j.ejmech.2019.06.027
(2019)Doi:10.1246/bcsj.37.204
(1964)Doi:10.1002/hlca.19980810304
(1998)Doi:10.1002/pola.27417
(2014)Doi:10.1016/S0040-4039(00)95814-3
(1987)